Dr. Andrea Loewendorf, PhD

I am a female scientist returning to Berlin after "the American experience": cancer, bankruptcy. With a background in immunology and a lifelong commitment to science, I’ve seen how US systems fail the vulnerable.

I’m not here to continue —I’m here to start over and build forward. I bring not only deep scientific expertise, but the clarity that comes from lived experience.

My mission is to make medicine inclusive, human, and just. Communication is key to that mission.

Professional Summary
• Life scientist with experience therapy development, resulting in marketed therapeutic, key player in the acquisition of the main asset of a biotech.

• In-depth knowledge 20+ years of multidisciplinary research in a variety of scientific fields (with the eyes of an immunologist): lipid immunology such as eicosanoid pathways (inflammation, pain, hormones), herpesviruses, primary biliary cirrhosis and other autoimmune liver diseases, pregnancy and hypertensive pregnancy disorders, nuclear hormone receptors and their role in the immune system (peroxisome proliferator factors alpha, beta/delta, and gamma).

• Excels at how things connect to each other and fit into the larger picture, and is driven to solving “problems” such as “weird signal” in the data, or a biologic that “shouldn’t do that”, etc.

• Effective communicator between different stakeholders including establishing clinical trials at new sites, liaison between client and CRO and/or academia.

Fields of Expertise
Autoimmune liver diseases, role of nuclear hormone receptors in immunology, immune aspects of pregnancy and hypertensive pregnancy disorders including preeclampsia, immune tolerance.

Skill Set
• Clinical/Research Program Lead: Experimental – and project lead in a clinical and preclinical setting. Coordination of the stakeholders, project management tasks, obtaining and managing IRB/IACUC permissions, protocols, and paperwork, patient outreach – and retention strategies.

• Exploration of novel clinical entities: Deep-dive into asset capabilities and risks, MOAs, clinical performance, clinical needs, clinical trial design, and other thought processes around a new/additional indication.

• Practical experience: clinical flow cytometry, research flow cytometry, Biosafety Level II animal work, sterile stem cell line work, Radiation Safety Officer, Institutional Animal Research and Care Committee work, Diagnostic immunology, clinical research lead, experimental design, CRO project lead, flow cytometry optimization, project management

Work Experience
- Founder and CEO, ImmunoVation, LLC 2019 – to date
Immunology and Beyond Consulting Services.

- Head of Laboratory. Huntington Medical Research Institutes 2015 - 2019
Treatments for acute and long-term effects of preeclampsia.

- Research Associate II. University of California Los Angeles 2012 - 2015
Adaptive and innate immune system during healthy and preeclamptic pregnancy.

- Project lead. Loma Linda University, 2011 – 2012
The antigenicity of cell products from induced pluripotent stem cells

- Post-doctoral Fellow. La Jolla Institute for Allergy and Immunology 2006 - 2011
Cytomegalovirus immunomodulation on early and late antiviral immune responses.

Education
- Ph.D. in Biology. University of Halle-Wittenberg, Saxony-Anhalt, Germany
- MS. in Biology. University of Halle-Wittenberg, Saxony-Anhalt, Germany

Publication (30+ peer-reviewed publications, 1500+ citations, h-factor=20, i-10 index=22)
The complete list of publications: https://scholar.google.com/citations?user=AqIecycAAAAJ
References available upon request.